A clinical-stage biopharmaceutical company focused on oncology therapeutics.

Given the type of HIV to advance when untreated, this could have disastrous consequences.in August 2010 , in a previous work to handle the AIDS medication crisis in Florida, AHF proposed an application that could have streamlined the medication donation procedure by centralizing the option of free of charge treatment for individuals at the pharmacy level.. Arno Therapeutics to commence Phase 1 clinical study of AR-12 in adult patients with lymphoma Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the dosing of the first individual in a Stage I clinical research of AR-12 in adult sufferers with advanced or recurrent solid tumors or lymphoma.The mortality price after cirrhosis is rolling out is 2-5 percent each year. End-stage liver disease because of HCV infection presently represents the major trigger for liver transplantation under western culture. About Boehringer Ingelheim in Virology Boehringer Ingelheim provides a lot more than 6,900 scientists employed in cross disciplinary groups in your global R&D network in six huge therapeutic areas, including virology. This Phase II program helps the investigation of BI 201335 in Stage III trials. Boehringer Ingelheim can be developing BI 207127, an NS5B RNA-dependent polymerase inhibitor which has completed Stage I clinical trials.